The encumbrance of antimicrobial resistance worldwide is substantive and likely to rise without any appropriate treatment which has enhanced the urge for the development of either new antibiotics or adjuvant therapy with antibiotics. Thus, we aimed to study a comparative antibiogram pattern of 758 clinical isolates collected from Pawana Hospital and Accord SDH, Pune (India), towards Elores (a novel antibiotic and adjutant entity of ceftriaxone, sulbactam and disodium edetate) and other antibiotics (imipenem, meropenem and piperacillin + tazobactam). Methods: The clinical samples collected from outpatients and inpatients during a period of one year (January, 2018 to January, 2019), from Pawana Hospital and Accord SDH, Pune (India) and were further subjected to bacterial identification. Antibiotic susceptibility testing was executed in accordance with the recommendations of Clinical Laboratory Standards Institute (CLSI) guidelines. Results: Out of 758 collected samples, urine samples contributed 69.41 and 37.63% among Enterobacteriaceae and Non-Enterobacteriaceae followed by pus (20.25 and 19.35%) and sputum (4.2 and 19.89%) while <4% and <12% Enterobacteriaceae and Non-Enterobacteriaceae isolates were collected from rest of the specimen. E. coli were found most prevalent (50.13%) along with 19.13 and 16.09% prevalence of Pseudomonas spp. and Klebsiella spp. whereas rest of the
INTRODUCTION
Antibiotic resistance is a significant health, social and economic problem at this time which has become a biological risk, increases morbidity and mortality of mankind [1] . It has been estimated that by 2050, 10 million lives a year will be at risk due to emergence of the infections raised by antimicrobial resistant pathogens [2] . Nowadays some of the infectious diseases have become virtually untreatable due to these resistant super bugs which are a matter of deep concern to the clinicians. Though, dealing with gram positive resistant pathogens is important concern but presently the continuous spread of resistant gram negative bacteria is currently the most imperative emerging issue. Antibiotic resistance issue is perturbed for the several reasons including treatments options are limited, resistance has spread widely on several fronts like horizontal gene transfer, pose significant challenges for infection control, associate with increased mortality and economic cost. Three particular problematic gram negative pathogens which are excessively obsessed with resistance are identified includes Enterobacteriaceae, Acinetobacter spp. and Pseudomonas spp. [3] . Earlier reports have revealed 66-80% resistance among gram negative bacteria against cephalosporin drugs and ß lactam-ß lactamase inhibitor (BL-BLI) antibiotics [4, 5, 6, 7] . Recently, resistance was also observed up to 50-61% among clinical isolates towards third generation cephalosporins [8] and resistance of 17 to 38% resistance among gram negative pathogens towards aminoglycosides [9] .
Rise in fluoroquinolone resistance among Enterobacteriaceae causing community acquired or healthcare associated urinary tract infections and intraabdominal infections, exceeding 50% was also reported in some parts of the world, particularly in Asia [10] . Resistance to imipenem and other carbapenems have also been studied globally among clinical bacterial isolates [11, 12] . Mechanism behind antimicrobial resistance in these microorganism includes production of extended spectrum ß lactamases (ESBL) and metallo ß lactamase (MBL), changes in membrane permeability, over-expression of efflux pump and production of biofilms etc. [13, 14, 15, 16] .
Overuse of antibiotics is considered as the prime reason for hike in antimicrobial resistance. Many countries like BRICS (Brazil, Russia, India, China and South Africa) have accounted for 3/4 th of total usage of antibiotic in the world [17] . Likewise ß lactam antibiotics usage reports for 50% of global antibiotic consumption [6] . Considering the rise in the predominance of multidrug resistant pathogens globally, there is a need to study the prevalence and susceptibility profile of various pathogens. Surveillance studies provide important information that allows for the identification of trends in pathogen incidence and antimicrobial resistance, including identification of emerging pathogens at national and global levels so there is a need of routine surveillance because it ensures the accurate information in order to establish, modifies the treatment guidelines and guides the clinicians for the prescription of appropriate empirical antimicrobial therapy. In view of the above data, the increasing rate of the antibiotic resistance and its impact on treatment failure compelled to screen alternative approaches by which the increasing mortality rate because of failure of drug therapy can be controlled. The concept of adjuvant addition to antibiotic (Elores) has been recently introduced and a great success has been reported. Hence, we aimed to compare the susceptibility profiles of different drugs such as imipenem, meropenem and piperacillin + tazobactam with Elores towards different clinical bacteria isolated from various clinical samples at Pawana Hospital and Accord SDH, Pune (India).
MATERIALS AND METHODS

Sample Collection
Different clinical samples such as bronchoalveolar fluid, body secretion, urine, blood, pus swabs and sputum specimen were collected from patients in a period of one year (January, 2018 to January, 2019), from Pawana Hospital and Accord SDH, Pune (India).
Isolation and Identification of Microbes
All the samples were collected aseptically in sterile containers in sufficient amount and inoculated on the different selective and nonselective culture media as per the standard microbiological techniques ( Table 1) . The collection and processing of the samples were done as per a common Standard Operating Procedures.
Antibiotic Susceptibility Testing
Antimicrobial susceptibility testing was done by Kirby-Bauer disk diffusion method as recommended by the Clinical Laboratory Standards Institute (CLSI) guidelines [18] . In brief, Inoculum of 0.5 McFarland standards turbidity was prepared in a Mueller-Hinton broth (MHB, Hi-Media, Mumbai, India) from isolated colony of pathogens selected from 18-24 hour agar plates. Within 15 minutes, a sterile cotton swab was dipped into the inoculum suspension. The swab was rotated several times and pressed firmly against the inside wall of the tube above the fluid level and inoculated on the dried surface of a Mueller-Hinton agar (MHA) plate by streaking the swab over it. For even distribution of inoculum, the swab was streaked two more times at 60° over the agar surface. After 3-5 minutes, antibiotic discs were applied and pressed down to ensure complete contact with agar surface. The discs were distributed evenly to ensure a minimum distance of 24 mm from center to center. The plates are then inverted and incubated for 16-18 hrs aerobically at 37°C within 15 minutes of disc application. Antibiotics sensitivity disc of Elores (45 μg) were obtained from Abtek while rest of the antibiotic discs such as piperacillin-tazobactam (110 μg), meropenem (10 μg) and imipenem (10 μg) were obtained from HiMedia, India. The zone diameters of each drug are interpreted using the criteria published by the Clinical and Laboratory Standards Institute (CLSI) as well as in-house for Elores.
RESULTS AND DISCUSSION
Infections caused by gram negative bacteria are a matter of concern worldwide. Due to extensive use of antibiotics and lapses in effective infection control measures, resistance among clinical pathogens is rising. For overcoming resistance, it's significant to monitor the change in susceptibility pattern among isolates towards antibacterial agents in the different hospitals of the world.
In Table 3 depicts the prevalence percentage of clinical pathogens among different clinical samples. Present results were correlated and also noted similar findings [19, 20] .
On the basis of morphological and biochemical screening most prevalent pathogens (50.13%) were E. coli, Pseudomonas spp. (19.13%), Klebsiella spp. (16.09%), Enterobacter spp. (6.07%) and Acinetobacter spp. (5.41%). Many studies have also revealed that gram negative bacteria as a major opportunistic and frequent pathogens and are extremely prevalent in hospital-associated infections which favors recent study [17, 21] . Clinical pathogens like Proteus spp., Morganella spp., Providencia spp. and Citrobacter spp. were found least prevalent <2% (Fig. 1) . Incidences of these isolates in clinical specimens corroborates with earlier studies [22, 23, 24, 25] .
Antibiogram profile of all the pathogens obtained from clinical specimens is presented in Fig. 2 . Present data suggests higher activity of Elores (87.80%) against clinical isolates and found 26-40% superior over other tested drugs such as meropenem (62.67%), imipenem (60.95%) and piperacillin+tazobactam (48.42%) (Fig. 2) . Similar pattern was observed towards (Fig. 4) .
Earlier studies also reported >60% sensitivity of imipenem and meropenem drugs against gram negative isolates which supports present data [26, 27] . Likewise, similar results (22-78%) were observed by for gram negative pathogens against piperacillin+tazobactam [28] . In the light of above discussions, it is evident that Elores (a novel Antibiotic adjuvant entity) can be considered as a choice of drug in the treatment of infective diseases caused by multidrug resistant gram negative pathogens.
CONCLUSION
These results highlight that the antibacterial activity of Elores to be the most susceptible (95.10%) towards Enterobacteriaceae isolates, which was approximately 31-50% more sensitive than other test drugs. Similar pattern was obtained for Non-enterobacteriaceae isolates (62.90%)
where Elores contributed approximately 1-5% higher activity. More than 79% shift has also been observed from imipenem, meropenem and piperacillin + tazobactam resistant isolates towards Elores susceptible.
Therefore, Elores (Antibiotic Adjuvant Entity) can be used as an alternate in clinical settings to target drug-resistant bacteria due to its resistance breaking efficacy.
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